• Twitter Clean
  • w-facebook

DRW (Europe) Ltd

Suite 12, Science Village

Chesterford Research Park

Little Chesterford, CB10 1XL

UK

© 2019 DRW Ltd.

DRW (US) Ltd

845 Embedded Way

Suite 150

San Jose, CA 95138

USA

SAMBA II: A REVOLUTION IN POINT OF CARE DIAGNOSTICS

SAMBA II

The provision of fast and reliable diagnoses, together with a means of accurately measuring viral load amongst HIV carrying patients has long been perceived as an absolute priority for health care professionals working in the developing world. Moreover, the inability to offer these without recourse to specialist expertise and large central laboratories has proven a substantial obstacle to improving health care and patient outcomes particularly in the resource-limited areas of sub-Saharan Africa.  DRW's SAMBA II overcomes all of these obstacles and offers a complete cost-effective diagnostic service at the point of care.

 

After field trials in Kenya and Zimbabwe, SAMBA II will be launched officially at the 20th International Aids Conference in Melbourne in July 2014.  It represents a major breakthrough in diagnostics and viral load measurement.